Position in BIVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19
-$18 QoQ
Shares Held
10
-63.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 36 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,606,617 across 416 Biotechnology names. BIVI ranks #401 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in BIVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19 | 10 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37 | 27 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $33 | 29 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $83 | 44 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $365 | 395 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,367 | 1,395 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,090 | 1,545 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $660 | 550 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,204 | 5,499 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,964 | 9,386 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $10,841 | 8,605 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $21,141 | 6,200 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $29,923 | 6,943 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $45,046 | 5,575 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $54,730 | 7,044 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,685 | 2,685 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,889 | 2,683 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,654 | 2,681 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $135 | 30 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $200 | 30 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $237 | 14 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $270 | 14 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $242 | 14 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||